Focus on Opioid Use Disorder and Treatment: The Genetics of Addiction-How Discovery Is Informing the Path Forward for Opioid Use Disorder Treatment, Intervention, and Prevention

---

ONLINECMEOpioidDEA-Required Opioid TrainingComplimentary - No FeeState Required CME

Tuesday, November 23, 2021, 4:00 PM - Monday, March 4, 2024, 5:30 PM

The opioid crisis has invaded every corner of the US. And with the highest rate of overdose death among major cities, Philadelphia has been hit especially hard — a statistic that COVID-19 has only exacerbated. How do you begin to tackle multiple complex public health emergencies? Is there hope for life beyond addiction?

Join Penn Medicine faculty as they discuss the inroads being made in this fight. Learn how research on the disease of addiction at Penn is setting new standards of care, driving more effective treatment protocols, and establishing the role of genetics in developing the next generation of interventions. 

This educational outreach event is the second in an ongoing series open to the community, we hope you will join us in the future to learn more.

Content Last Review: March 4, 2024

1. Describe how Penn Medicine programs and its faculty leaders are addressing Opioid Use Disorder—including but not limited to clinical care and research
2. Review research on the genetics of addiction and how physician-scientists are more effectively studying the environmental and inherited factors that contribute to Opioid Use Disorder and other substance use disorders

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Physicians: Penn Medicine designates this live internet activity for a maximum of 1.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Opioid Education: This activity is approved for 1.50 hours in Opioid Education.

AMA PRA Category 1 Credits™ (1.50 hours), Non-Physician Attendance / Participation (1.50 hours), Opioid Education (1.50 hours)

Mitigation of Relevant Financial Relationships

Penn Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

No faculty are available for this activity at this time.